2. Review management strategies for hypersomnia and
narcolepsy in children; and
3. Discuss hypersomnia associated with childhood
neurological disorders.
O31: Insomnia: Modifying Factors
2:45pm – 4:45pm
Psychologist Level of Content:
Intermediate
Objective:
Evaluate factors modifying insomnia.
O32: Biobehavioral Impact of Short Sleep
Duration and Shift Work
2:45pm – 4:45pm
Psychologist Level of Content:
Intermediate
Objective:
Describe the adverse consequences of short
sleep duration, whether natural or induced by work
schedule, on behavior, performance and health.
S21: The Importance of Sleep
Disturbance in Mood Disorders:
Evidence from Clinical Interventions and
Scientific Experiments
2:45pm – 4:45pm
Chair:
Jared Minkel, PhD
Faculty:
Ruth Benca, MD, PhD; Andrew Krystal, MD; and
Rachel Manber, PhD
Psychologist Level of Content:
Intermediate
Objectives:
1. Discuss the nature of sleep abnormalities in patients
with major depression;
2. Describe the beneficial effects of treating sleep
problems in patients with major depression; and
3. Identify behavioral and biological consequences of
experimental sleep deprivation on emotional function.
S22: Autonomic Consequences of Sleep Loss
and Risk of Hypertension
2:45pm – 4:45pm
Chair:
Huan Yang, PhD
Faculty:
Jason Carter, PhD; Julio Fernandez-Mendoza,
PhD; and Monika Haack, PhD
Psychologist Level of Content:
Intermediate
Objectives:
1. Review the autonomic consequences of sleep
loss which could contribute to increased risk of
hypertension;
2. Recognize the sex differences in autonomic and
hemodynamic responses to sleep loss; and
3. Discuss a novel behavioral approach to lowering
blood pressure.
S23: Does OSA Cause Metabolic
Consequences: Summary of the Existing
Evidence and Presentation of New Data
2:45pm – 4:45pm
Co-chairs:
Ronald Grunstein, MD, PhD; and Camilla
Hoyos, PhD
Faculty:
Vsevolod Polotsky, MD, PhD; Naresh
Punjabi, MD; and Esra Tasali, MD
Psychologist Level of Content:
Introductory
Objectives:
1. Describe the physiological mechanisms for why OSA
may cause metabolic consequence;
2. Discuss evidence from randomized CPAP treatment
studies investigating markers of metabolic health;
3. Review the most recent data, some unpublished, from
randomized CPAP sham-controlled studies regarding
metabolic health in both non-diabetic and diabetic
patients; and
4. Identify the best direction to be taken for new research
in the area of metabolic health.
Wednesday
June 4
Tuesday
June 3
Sunday
June 1
Monday
June 2
Saturday
May 31
45
